HELENA LABORATORIES, CORP. FDA Inspection Record
HELENA LABORATORIES, CORP. is an FDA-registered facility (FEI 1618982) located in BEAUMONT, TX, US. RegDataLab tracks 4 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Dec 14, 2018: Voluntary Action Indicated (VAI)
- Inspections on record
- 4 (1 OAI, 3 VAI)
- Last OAI inspection
- Jul 21, 2017
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 15, latest Sep 14, 2026
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Dec 14, 2018 | Voluntary Action Indicated (VAI) | Lack of or inadequate procedures (21 CFR 820.100(a)) Maintenance schedule, Lack of or inadequate schedule (21 CFR 820.70(g)(1)) Process control procedures, Lack of or inadequate procedures (21 CFR 820.70(a)) Lack of or inadequate process validation (21 CFR 820.75(a)) |
| Jul 21, 2017 | Official Action Indicated (OAI) | Documentation (21 CFR 820.75(a)) Lack/Inad procedure-Monitoring/Control of Validated Proces (21 CFR 820.75(b)) Maintenance schedule, Lack of or inadequate schedule (21 CFR 820.70(g)(1)) Calibration, Inspection, etc. Procedures Lack of or Inadequ (21 CFR 820.72(a)) and 4 more |
| Mar 1, 2013 | Voluntary Action Indicated (VAI) | Lack of or inadequate complaint procedures (21 CFR 820.198(a)) Procedures not adequately established or maintained (21 CFR 820.40) Design plans - Lack of or inadequate (21 CFR 820.30(b)) Design input - documentation (21 CFR 820.30(c)) and 5 more |
| Oct 29, 2010 | Voluntary Action Indicated (VAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Sep 14, 2026 | Class II | Z-0469-2027 | V8 Serum Protein SPE Kit, Cat. No.: 1805, containing V8 SPE Diluent, Product No.: 552512 Serum protein kit has a diluent that may produce a decrease in the albumin fraction with a corresponding increase in the beta and gamma… |
| May 2, 2023 | Class II | Z-1975-2023 | Serrated Blade Applicator Kit (12 Sample), REF: 552687, For use with the Spife Nexus… Packaging for a serrated blade applicator kit (12 Sample) may contain a serrated blade applicator (18 sample). This results in a… |
| Apr 6, 2022 | Class II | Z-1244-2022 | V8 Immunodisplacement Kit REF 1803 Due to microbial growth causing interference with interpretation. |
| Jan 5, 2021 | Class II | Z-1108-2021 | Cascade Abrazo aPTT Test Card - Product Usage: are to be used with the Cascade Abrazo… Intermittent potential for shorter than expected clot times. |
| Nov 9, 2020 | Class II | Z-0635-2021 | K-ACT Actalyke Clotting Test Tubes that are used in the: ACTALYKE XL ACTIVATED CLOTTING… Due to complaints received associated with cracked/split test tube caps. |
| Aug 8, 2018 | Class II | Z-1949-2019 | ColoCARE, Cat. No. 5650, packaged 250 envelopes/box, For In-Vitro Diagnostic Use. The… and 1 more product The positive control on some tests of the lots did not appropriately react within the specified timeframe to verify the test was functioning… |
| May 23, 2018 | Class III | Z-0536-2020 | Platelet Aggregation Kit, Cat. No.5369, For use in platelet aggregation studies, Contains… and 1 more product Through an investigation, it has been determined that vials of Collagen packaged within the Collagen Reagent and Platelet Aggregation Kit… |
| Feb 27, 2018 | Class III | Z-0297-2020 | SPIFE Alkaline Hemoglobin Kit, Cat. No. 3415,
for use in the separation and… Lots of gel kits contained a newer revision of the Customer Procedures instructions than intended. The incorrect inserts refer to updated… |
| Dec 7, 2017 | Class II | Z-2761-2019 | Cascade Abrazo aPTT Test Card, Model 5722, For Export Only. The firm name on the label is… Some of the cards show occasional shorter clot times than the expected variation resulting in a potential false negative result on the… |
| Jul 21, 2017 | Class II | Z-0045-2020 | SPIFE ImmunoFix-6 Kit, Cat. No. 3401, 3401T, For In-Vitro Diagnostic Use. The firm name… The plates do not have wells punched for the controls in the patient 1 area. |
FDA record score
25 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
16 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified OAI | Jul 21, 2017 | 30 x 0.25 | 7.5 |
| Class II recall Z-0469-2027, this FEI as the recalling firm | Sep 14, 2026 | 4 x 1 | 4 |
| Class II recall Z-1975-2023, this FEI as the recalling firm | May 2, 2023 | 4 x 0.6 | 2.4 |
| Class II recall Z-1244-2022, this FEI as the recalling firm | Apr 6, 2022 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | Dec 14, 2018 | 6 x 0.25 | 1.5 |
| Class II recall Z-1108-2021, this FEI as the recalling firm | Jan 5, 2021 | 4 x 0.25 | 1 |
| Class II recall Z-0635-2021, this FEI as the recalling firm | Nov 9, 2020 | 4 x 0.25 | 1 |
| Class II recall Z-1949-2019, this FEI as the recalling firm | Aug 8, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-2761-2019, this FEI as the recalling firm | Dec 7, 2017 | 4 x 0.25 | 1 |
| Class II recall Z-0045-2020, this FEI as the recalling firm | Jul 21, 2017 | 4 x 0.25 | 1 |
| Class II recall Z-0106-2019, this FEI as the recalling firm | Apr 4, 2017 | 4 x 0.25 | 1 |
| Class II recall Z-0561-2019, this FEI as the recalling firm | Feb 24, 2017 | 4 x 0.25 | 1 |
| Class II recall Z-2434-2019, this FEI as the recalling firm | Oct 14, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall Z-0594-2019, this FEI as the recalling firm | Apr 20, 2016 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Mar 1, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Oct 29, 2010 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 22, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
| Warning letter text | Nov 22, 2026 | Newest record Nov 17, 2026 | Current |
| Recalls (Enforcement Report) | Nov 22, 2026 | Newest record Nov 18, 2026 | Current |
| Form 483s and inspection documents | Nov 18, 2026 | Newest record Nov 17, 2026 | Current |
| Import refusals | Nov 22, 2026 | Newest record Nov 12, 2026 | Current |
Reviewing HELENA LABORATORIES, CORP. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check HELENA LABORATORIES, CORP. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Helena Laboratories, Corp.
- Location
- BEAUMONT, TX (US)
- Source
- device